Two of the three hormones retatrutide mimics are already available in FDA-approved weight loss medications, so the patient who was granted early access likely sought benefits primarily stemming from the third hormone, which activates the livers glucagon receptors
Mark Seeley, M.D., PhD, director of Michigan Diabetes Research & Training Center
In the Microdose GLP-1 Rx Program, we set out to virtually eliminate side effects for the vast majority, so that more than 70% of people would encounter no side effects
This content is for informational purposes only and is not a substitute for professional medical advice.
If you have type 2 diabetes, prediabetes, or obesity-related health conditions, consult your healthcare provider about appropriate management, which may include GLP-1 medications alongside lifestyle modifications
One way to picture the progression is by comparing generations of treatment